Launch of the group is based on innovation and efficiency
ADCOS is a Brazilian brand of dermocosmetics that brings in its DNA the proven effectiveness of its products. In June 2023, Ada launches Bioarch, a new brand focused on developing solutions for aesthetic dermatological treatments. With that, ADCOS Dermocosmticos, ADCOS Pro and Bioarch become part of the ADCOS Group. This change represents a milestone in the company’s trajectory and allows it to further expand its presence in the market with aesthetic and dermatological solutions.
With complete and synergistic formulas that promise to act effectively through multiple mechanisms of action, Bioarch will make patient safety and comfort a priority in all formulations. The new brand hits the market, uniting advanced aesthetic medicine and solid experience, focusing on strengthening aesthetic health with safe, highly effective and scientifically proven products, created exclusively for health professionals.
With a team of 40 professionals trained in pharmacy and dermatology, the brand will focus on developing quality products with proven effectiveness. The new brand’s products will only be sold to qualified health professionals (physicians, dentists, biomedical doctors, pharmacists and nurses).
The ADCOS group seeks to expand into new luxury malls in Brazil and increase its presence in pharmacies, managing to serve all regions of Brazil. In July 2023, ADCOS Dermocosmticos will open stores at Shopping Cidade Jardim and CJ Shops. In the medium term, ADCOS should take its first solo steps in Europe and the United States, added Lucas Motta, commercial and marketing director of the ADCOS group.
With the presence of 150 stores spread across the main cities of the country, the group continues to expand, with the goal of reaching the end of 2023 with 200 stores, expanding operations in relevant squares to bring more beauty and health to its customers. The expectation for 2023 is to surpass R600 million in sales as a group. Bioarch arrives with the goal of representing 10% of revenue in the 1st year.